These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11583747)

  • 61. Better functional status in American than Canadian patients with heart disease: an effect of medical care?
    Pilote L; Bourassa MG; Bacon C; Bost J; Detre K; Mark DB; Pitt B; Reeder G; Rogers WJ; Ryan T
    J Am Coll Cardiol; 1995 Nov; 26(5):1115-20. PubMed ID: 7594019
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gender differences in clinical status at time of coronary revascularisation in Spain.
    Aguilar MD; Lázaro P; Fitch K; Luengo S
    J Epidemiol Community Health; 2002 Jul; 56(7):555-9. PubMed ID: 12080167
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of multi-vessel coronary artery disease. What is the optimal revascularisation approach? What do we know, what will we learn?
    Vaina S; Stefanadis C
    Hellenic J Cardiol; 2007; 48(1):1-4. PubMed ID: 17388103
    [No Abstract]   [Full Text] [Related]  

  • 64. Delay to invasive investigation and revascularisation for coronary heart disease in south west Thames region: a two tier system?
    Marber M; MacRae C; Joy M
    BMJ; 1991 May; 302(6786):1189-91. PubMed ID: 2043817
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Health-related quality of life following percutaneous coronary intervention: the impact of age on outcome at 1 year.
    Moore R; Pedel S; Lowe R; Perry R
    Am J Geriatr Cardiol; 2006; 15(3):161-4. PubMed ID: 16687968
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of coronary heart disease in the elderly.
    Rogers WB; von Dohlen TW; Frank MJ
    Clin Cardiol; 1991 Aug; 14(8):635-42. PubMed ID: 1914266
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ISCHEMIA Trial: Key Questions and Answers.
    Lopez-Sendon J; Moreno R; Tamargo J
    Eur Cardiol; 2021 Feb; 16():e34. PubMed ID: 34603514
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of priority for coronary revascularisation procedures. Revascularisation Panel and Consensus Methods Group.
    Naylor CD; Baigrie RS; Goldman BS; Basinski A
    Lancet; 1990 May; 335(8697):1070-3. PubMed ID: 1970377
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is There Still a Place for Revascularisation in the Management of Stable Coronary Artery Disease Following the ISCHEMIA Trial?
    Gala ABE; Curzen N
    Heart Int; 2020; 14(1):13-15. PubMed ID: 36277662
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence-based assessment of the benefit of revascularisation in coronary disease: beyond the randomised trials.
    French JK; Webster MW; Neutze JM; White HD
    Aust N Z J Med; 1996 Aug; 26(4):490-4. PubMed ID: 8873931
    [No Abstract]   [Full Text] [Related]  

  • 71. Do routine clinic visits prevent de-stabilization in patients awaiting coronary revascularization?
    Lim R; Kreidieh I; Dymond DS
    J R Soc Med; 1991 Nov; 84(11):660-1. PubMed ID: 1744871
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Geographical variation in coronary revascularisation rates.
    Smith LK
    J Epidemiol Community Health; 1996 Apr; 50(2):227. PubMed ID: 8762396
    [No Abstract]   [Full Text] [Related]  

  • 73. Reporting on reports--cardiological intervention in elderly patients.
    Lawson-Matthew PJ; Channer KS
    J R Coll Physicians Lond; 1995; 29(1):11-4. PubMed ID: 7738873
    [TBL] [Abstract][Full Text] [Related]  

  • 74. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial and the appropriateness of revascularization.
    Narayan P
    Indian J Thorac Cardiovasc Surg; 2020 Nov; 36(6):664-667. PubMed ID: 33100632
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Arterial grafting for coronary revascularisation and the illusive search for truth.
    Kurlansky PA
    Heart; 2017 Sep; 103(18):1394-1395. PubMed ID: 28701472
    [No Abstract]   [Full Text] [Related]  

  • 76. [Quality of life 2 years after coronary revascularization].
    Pinheiro de Melo EM; Lopes Ferreira P
    Enferm Clin; 2007; 17(6):309-17. PubMed ID: 18039439
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Coronary heart disease. Stable and unstable syndromes.
    Friesinger GC; Ryan TJ
    Cardiol Clin; 1999 Feb; 17(1):93-122. PubMed ID: 10093768
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Revascularisation, periprocedural events and survival - and the survival of the randomised controlled trial.
    Lansky AJ; Ahmad Y
    EuroIntervention; 2023 Mar; 18(15):1218-1219. PubMed ID: 36939109
    [No Abstract]   [Full Text] [Related]  

  • 79. ISCHEMIA Trial and the Significance of MI.
    Arias EA; Damas-de Los Santos F; Ontiveros-Mercado H
    Interv Cardiol; 2020 Apr; 15():e14. PubMed ID: 33163087
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Trimetazidine and Other Metabolic Modifiers.
    Guarini G; Huqi A; Morrone D; Capozza PFG; Marzilli M
    Eur Cardiol; 2018 Dec; 13(2):104-111. PubMed ID: 30697354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.